Moxisylyte hydrochlorideProduct ingredient for Moxisylyte

Moxisylyte, denominated as thymoxamine in the UK, is a specific and orally active α1-adrenergic antagonist.¹⁰ According to the WHO, moxisylyte is approved since 1987⁹ and in the same year, it acquired the denomination of orphan product by the FDA.¹¹ This drug was developed by the Japanese company Fujirebio and also by the American company Iolab in the late 80s.